Follicular Lymphoma
Showing 1 - 25 of 267
DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Xiamen (Lenalidomide combined with G-CHOP (LO CHOP))
Recruiting
- DLBCL - Diffuse Large B Cell Lymphoma
- Follicular Lymphoma
- Lenalidomide combined with G-CHOP (LO CHOP)
-
Xiamen, Fujian, ChinaBing Xu
Nov 28, 2023
Relmacabtagene Autoleucel in Hematologic Malignancies
Not yet recruiting
- Lymphoma, B-Cell
- +2 more
- Relmacabtagene Autoleucel
-
Beijing, Beijing, China
- +1 more
Nov 15, 2023
Venetoclax Tablets Crushed and Dissolved Into a Solution
Not yet recruiting
- Hematologic Malignancy
- +18 more
- 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Nov 8, 2023
Follicular Lymphoma Trial in Duarte, Irvine (procedure, other, biological, drug)
Not yet recruiting
- Follicular Lymphoma
- Biospecimen Collection
- +7 more
-
Duarte, California
- +1 more
Oct 27, 2023
Follicular Lymphoma, Tumor Trial in Houston (Obinutuzumab, CC-99282)
Not yet recruiting
- Follicular Lymphoma
- Tumor
-
Houston, TexasM D Anderson Cancer Center
Oct 30, 2023
COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in
Not yet recruiting
- Follicular Lymphoma
- Cellular immunity vs SARS-CoV-2
- +6 more
-
Alessandria, IT, Italy
- +13 more
Oct 10, 2023
Follicular Lymphoma, Refractory Follicular Lymphoma Trial (Tazverik (Tazemetostat))
Not yet recruiting
- Follicular Lymphoma
- Refractory Follicular Lymphoma
- Tazverik (Tazemetostat)
- (no location specified)
Oct 6, 2023
Follicular Lymphoma Trial (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine phosphate)
Not yet recruiting
- Follicular Lymphoma
- Axicabtagene Ciloleucel
- +5 more
- (no location specified)
Sep 21, 2023
Patients Undergoing Follicular Lymphoma Clinical Research
Not yet recruiting
- Follicular Lymphoma
-
San Francisco, CaliforniaPower Life Sciences
Sep 15, 2023
Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,
Not yet recruiting
- Non-hodgkin Lymphoma
- +9 more
- CD79b-19 CAR T cells
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 6, 2023
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)
Not yet recruiting
- Triple Negative Breast Cancer
- +13 more
- (no location specified)
Aug 29, 2023
Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in United States (P-CD19CD20-ALLO1, Rimiducid)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- +5 more
- P-CD19CD20-ALLO1
- Rimiducid
-
La Jolla, California
- +7 more
Aug 25, 2023
Lymphoma, B-Cell, Relapsed Cancer, Refractory Lymphoma Trial in Boston (Adaptive Bridging Radiation Therapy (ABRT))
Not yet recruiting
- Lymphoma, B-Cell
- +7 more
- Adaptive Bridging Radiation Therapy (ABRT)
-
Boston, MassachusettsDana-Farber Cancer Institute
Aug 16, 2023
Follicular Lymphoma Trial in New York (Mosunetuzumab, Tazemetostat Pill)
Not yet recruiting
- Follicular Lymphoma
- Mosunetuzumab
- Tazemetostat Pill
-
New York, New YorkWeill Cornell Medicine/NewYork-Presbyterian Hospital
Aug 8, 2023
Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (Pirtobrutinib, LV20.19 CAR T cells)
Not yet recruiting
- Non Hodgkin Lymphoma
- +5 more
- Pirtobrutinib
- LV20.19 CAR T cells
- (no location specified)
Aug 4, 2023
Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)
Not yet recruiting
- Follicular Lymphoma
- +3 more
- Tazemetostat Pill
-
New York, New YorkWeill Cornell Medicine/NewYork-Presbyterian Hospital
Jun 28, 2023
Follicular Lymphoma Trial in Italy (Radiotherapy, Radiotherapy plus Obinotuzumab)
Not yet recruiting
- Follicular Lymphoma
- Radiotherapy
- Radiotherapy plus Obinotuzumab
-
Alessandria, Italy
- +47 more
Jun 26, 2023
Obinutuzumab-based Therapy for Previously Untreated FL
Recruiting
- Follicular Lymphoma
- Obinutuzumab
- +6 more
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 3, 2023
Follicular Lymphoma Trial in Shanghai (lenalidomide, rituximab, parsaclisib)
Not yet recruiting
- Follicular Lymphoma
- lenalidomide
- +2 more
-
Shanghai, Shanghai, ChinaRuijin hospital, school of medicine, Shanghai jiao tong universi
May 10, 2023
Obinutuzumab in Combination With Lenalidomide in Relapsed or
Recruiting
- Follicular Lymphoma
-
Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital ,Chinese Aca
Apr 27, 2023
Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)
Not yet recruiting
- Relapsed Non-Hodgkin Lymphoma
- +6 more
- (no location specified)
Apr 12, 2023
Advanced Follicular Lymphoma:Translational Study From FIL_FOLL12
Not yet recruiting
- Follicular Lymphoma
- EZH2 mutations/CNAs by droplet digital PCR (ddPCR)
- EZH2-derived gene expression signature by RNA-Seq
-
Alessandria, Italy
- +25 more
Apr 4, 2023
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,
Not yet recruiting
- Acute Myelogenous Leukemia
- +17 more
- Peripheral Blood Stem Cell Transplant
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Mar 27, 2023